Quaker Chemical director receives stock grant, surrenders shares

Quaker Chemical director Lucrece Foufopoulos - De Ridder reported routine equity compensation and related tax withholding.

Rhea-AI Filing Summary

Quaker Chemical director Lucrece Foufopoulos - De Ridder reported routine equity compensation and related tax withholding. On June 1, 2026, the director received 413 shares of common stock at $145.24 per share, reflecting 75% of the annual retainer paid in shares under the 2023 Director Stock Ownership Plan. On the same date, 124 shares were surrendered to cover statutory withholding taxes tied to these shares. After these transactions, the director directly owned 2,570 shares of Quaker Chemical common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Foufopoulos - De Ridder Lucrece

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	413	$145.24	$60K
Exercise Price or Tax Liability	Common Stock	124	$145.24	$18K

Holdings After Transaction: Common Stock — 2,570 shares (Direct)

Footnotes (2)

1. F1. Reflects 75% of the Director's annual retainer paid in shares pursuant to the 2023 Director Stock Ownership Plan.
2. F2. Shares surrendered by reporting person to satisfy statutory withholding tax obligation in connection with shares issued on June 1, 2026 under the Director Stock Ownership Plan.

Key Figures

Stock grant: 413 shares Shares surrendered for taxes: 124 shares Share price reference: $145.24 per share +2 more

5 metrics

Stock grant 413 shares Common Stock awarded on June 1, 2026

Shares surrendered for taxes 124 shares Statutory withholding obligation on June 1, 2026

Share price reference $145.24 per share Value used for both grant and surrender

Post-transaction holdings 2,694 shares Director’s direct ownership after transactions

Retainer portion in stock 75% of annual retainer Paid in shares under 2023 Director Stock Ownership Plan

Key Terms

Director Stock Ownership Plan, statutory withholding tax obligation, annual retainer, grant, award, or other acquisition, +1 more

5 terms

Director Stock Ownership Plan financial

"paid in shares pursuant to the 2023 Director Stock Ownership Plan"

statutory withholding tax obligation financial

"to satisfy statutory withholding tax obligation in connection with shares issued"

annual retainer financial

"Reflects 75% of the Director's annual retainer paid in shares"

grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

Payment of exercise price or tax liability by delivering securities financial

"transaction code description: Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Quaker Chemical (KWR) report for Lucrece Foufopoulos - De Ridder?

Quaker Chemical reported a stock grant and related tax withholding. The director received 413 shares of common stock and surrendered 124 shares to satisfy statutory tax withholding, both on June 1, 2026, under the company’s Director Stock Ownership Plan.

How many Quaker Chemical (KWR) shares does the director hold after this Form 4?

After the reported transactions, the director holds 2,694 shares. This total reflects the 413-share equity award credited to the director, net of 124 shares surrendered for statutory tax withholding obligations under the Director Stock Ownership Plan.

Was the Quaker Chemical (KWR) insider transaction an open-market buy or sell?

The filing shows no open-market buying or selling. The director received shares as a grant for board service and surrendered a portion of those shares solely to cover statutory withholding taxes, rather than trading in the open market.

What is the Quaker Chemical (KWR) 2023 Director Stock Ownership Plan mentioned in the Form 4?

The 2023 Director Stock Ownership Plan governs how directors receive stock-based pay. In this case, 75% of the director’s annual retainer was paid in shares, with some shares surrendered to satisfy statutory tax withholding obligations tied to that equity compensation.

At what price were the Quaker Chemical (KWR) shares valued in this insider filing?

The reported transactions used a price of $145.24 per share. Both the 413-share grant and the 124-share surrender for statutory withholding taxes referenced this same per-share value in the Form 4 disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foufopoulos - De Ridder Lucrece

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428-2380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		413(1)	A	$145.24	2,694	D
Common Stock	06/01/2026		F		124(2)	D	$145.24	2,570	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects 75% of the Director's annual retainer paid in shares pursuant to the 2023 Director Stock Ownership Plan.

2. Shares surrendered by reporting person to satisfy statutory withholding tax obligation in connection with shares issued on June 1, 2026 under the Director Stock Ownership Plan.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Lucrece Foufopoulos-De Ridder	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)